These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8693878)

  • 1. Value of GCDFP-15 (BRST-2) as a specific immunocytochemical marker for breast carcinoma in cytologic specimens.
    Fiel MI; Cernaianu G; Burstein DE; Batheja N
    Acta Cytol; 1996; 40(4):637-41. PubMed ID: 8693878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of gross cystic disease fluid protein-15 in distinguishing metastatic breast carcinomas among poorly differentiated neoplasms involving the ovary.
    Monteagudo C; Merino MJ; LaPorte N; Neumann RD
    Hum Pathol; 1991 Apr; 22(4):368-72. PubMed ID: 2050370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.
    Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ
    J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin.
    Wick MR; Lillemoe TJ; Copland GT; Swanson PE; Manivel JC; Kiang DT
    Hum Pathol; 1989 Mar; 20(3):281-7. PubMed ID: 2542151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic utility of mammaglobin and GCDFP-15 in the identification of metastatic breast carcinoma in fluid specimens.
    Yan Z; Gidley J; Horton D; Roberson J; Eltoum IE; Chhieng DC
    Diagn Cytopathol; 2009 Jul; 37(7):475-8. PubMed ID: 19217055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential sensitivity of estrogen/progesterone receptors and BRST-2 markers in metastatic ductal and lobular breast carcinoma to the skin.
    Wallace ML; Smoller BR
    Am J Dermatopathol; 1996 Jun; 18(3):241-7. PubMed ID: 8806958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.
    Shield PW; Papadimos DJ; Walsh MD
    Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can GATA3 Immunocytochemistry be Utilized as a Reliable Diagnostic Marker for Metastatic Breast Carcinoma in Cytological Materials? A Comparative Study with Mammaglobin and GCDFP-15 Expression.
    Hafez NH; Shaaban HM
    Turk Patoloji Derg; 2018; 34(2):143-149. PubMed ID: 29235613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of breast specific antigens and cytokeratins in metastatic breast carcinoma in the liver.
    Akasofu M; Kawahara E; Kurumaya H; Nakanishi I
    Acta Pathol Jpn; 1993 Dec; 43(12):736-44. PubMed ID: 7509105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic immunohistochemistry of cutaneous metastatic breast carcinoma: a statistical analysis of the utility of gross cystic disease fluid protein-15 and estrogen receptor protein.
    Ormsby AH; Snow JL; Su WP; Goellner JR
    J Am Acad Dermatol; 1995 May; 32(5 Pt 1):711-6. PubMed ID: 7722013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue.
    Satoh F; Umemura S; Osamura RY
    Breast Cancer; 2000 Jan; 7(1):49-55. PubMed ID: 11029771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical study with antibody to glycoprotein GCDFP-15 for metastatic lung cancer from breast cancer.
    Nonami Y; Hisa S; Yamamoto A; Sasaguri S; Kiyoku H; Kurumaya H
    J Cardiovasc Surg (Torino); 2001 Aug; 42(4):561-4. PubMed ID: 11455297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the primary site of metastatic adenocarcinoma in serous effusions. Value of an immunocytochemical panel added to the clinical arsenal.
    Longatto Filho A; Alves VA; Kanamura CT; Nonogaki S; Bortolan J; Lombardo V; Bisi H
    Acta Cytol; 2002; 46(4):651-8. PubMed ID: 12146025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Young investigator challenge: The utility of GATA3 immunohistochemistry in the evaluation of metastatic breast carcinomas in malignant effusions.
    Lew M; Pang JC; Jing X; Fields KL; Roh MH
    Cancer Cytopathol; 2015 Oct; 123(10):576-81. PubMed ID: 26465236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytologic features of pleural effusion in apocrine sweat gland carcinoma. A case report.
    Otani M; Maeda Y; Miyake Y; Miura M; Kudo M; Ebihara Y
    Acta Cytol; 2001; 45(1):74-8. PubMed ID: 11213508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids.
    Lee BH; Hecht JL; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2002 May; 117(5):745-50. PubMed ID: 12090423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signet ring variant of lobular carcinoma of the breast: a clinicopathologic and immunohistochemical study.
    Raju U; Ma CK; Shaw A
    Mod Pathol; 1993 Sep; 6(5):516-20. PubMed ID: 8248106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast.
    Pagani A; Sapino A; Eusebi V; Bergnolo P; Bussolati G
    Virchows Arch; 1994; 425(5):459-65. PubMed ID: 7850069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GCDFP-15 positive and TTF-1 negative primary lung neoplasms: a tissue microarray study of 381 primary lung tumors.
    Wang LJ; Greaves WO; Sabo E; Noble L; Tavares R; Ng T; DeLellis RA; Resnick MB
    Appl Immunohistochem Mol Morphol; 2009 Dec; 17(6):505-11. PubMed ID: 19620839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-cadherin immunohistochemical analysis of histiocytoid carcinoma of the breast.
    Gupta D; Croitoru CM; Ayala AG; Sahin AA; Middleton LP
    Ann Diagn Pathol; 2002 Jun; 6(3):141-7. PubMed ID: 12089723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.